SPC353
Evinacumab
Status:
VeittApplication date:
15.10.2021Application published:
15.11.2021Grant published:
15.7.2023
Max expiry date:
17.12.2036Medicine name:
EvkeezaMedicine for children:
Yes
Timeline
Today
15.10.2021Application
15.11.2021Publication
15.7.2023Registration
17.12.2036Expires
Marketing license
IS authorization number:
EU/1/21/1551/001-002Date:
20.7.2021
Foreign authorization number:
EU/1/21/1551Date:
17.6.2021
Owner
Name:
Regeneron Pharmaceuticals, IncAddress:
777 Old Saw Mill River Road, Tarrytown US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128 Reykjavík
Patent
Number:
EP2721065